| タイトル |
Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
|
| 著者 |
Tsukune Yutaka
Sasaki Makoto
Odajima Takeshi
Sunami Kazutaka
Takei Tomomi
Moriuchi Yukiyoshi
Iino Masaki
Isoda Atsushi
Nakaya Aya
Muta Tsuyoshi
Miyake Takaaki
Miyazaki Koji
Shimizu Takayuki
Nakajima Kei
Igarashi Aiko
Nagafuji Koji
Kurihara Taro
Aoyama Tomonori
Sugimori Hiroki
Komatsu Norio
|
| 収録物名 |
BLOOD CANCER JOURNAL
|
| 巻 | 7 |
| 収録物識別子 |
ISSN 2044-5385
|
| 言語 |
英語
|
| 資源タイプ | 学術雑誌論文 |
| 出版者 |
NATURE PUBLISHING GROUP
|
| 発行日 | 2017-11-23 |
| アクセス権 | メタデータのみ |
| 関連情報 |
[DOI] 10.1038/s41408-017-0002-2
[PMID] 29167420
|
| 備考 | We thank all the following physicians of the cooperating hospitals for providing the clinical data: Michiaki Koike (Juntendo University Shizuoka Hospital), Hideto Tamura and Keiichi Moriya (Nippon Medical School), Shigeki Ito and Maki Asahi (Iwate Medical University School of Medicine), Yoichi Imai and Junji Tanaka (Tokyo Women's Medical University), Hiroshi Handa and Hiromi Koiso (Gunma University), Sakae Tanosaki (The Fraternity Memorial Hospital), Yoshihiro Hatta (Nihon University School of Medicine), Jian Hua and Masao Hagihara (Eiju General Hospital), Ilseung Choi (National Hospital Organization Kyushu Cancer Center), Naoko Harada (National Hospital Organization Kumamoto Medical Center), Kensuke Ohta (Osaka Saiseikai Nakatsu Hospital), Toshihiro Fukushima (Kanazawa Medical University Hospital), Yoshitaka Imaizumi (Nagasaki University Hospital), Hiroyuki Kuroda (Steel Memorial Muroran Hospital), Yuichi Nakamura (Saitama Medical University Hospital), Tomoharu Takeoka (Otsu Red Cross Hospital), Mitsufumi Nishio (NTT Higashinihon Sapporo Hospital), Takeshi Yamashita (Keiju Kanazawa Hospital), Msayoshi Kobune (Sapporo Medical University School of Medicine), Nobuhiko Nakamura (Gifu University Hospital), Miyuki Ookura (University of Fukui Hospital), Eriko Sato (Juntendo University Nerima Hospital), Masahiro Onozawa (Hokkaido University Graduate School of Medicine), Shikiko Ueno (Kumamoto University Graduate School of Medicine), Riko Tsumanuma (Yamagata Prefectural Central Hospital), Hiroyuki Takamatsu (Kanazawa University Graduate School of Medical Science), Naoko Furuya (Tokyo Medical University), Yoshio Saburi (Oita Prefectural Hospital), Nobuhiko Uoshima (Japanese Red Cross Kyoto Daini Hospital), Tsuyoshi Takahashi (Mitsui Memorial Hospital), Satoru Hasuike (Faculty of Medicine, University of Miyazaki), Tadahiko Igarashi (Gunma Cancer Center), Akio Kohno (JA Aichi Konan Kosei Hospital), Kyoko Inokura (Faculty of Medicine, Yamagata University), Shigeru Hoshino (Saitama Red Cross Hospital), Nobuhito Ohno (Ikeda Hospital), Ayumi Numata (Kanagawa Cancer Center), Atsushi Inagaki (Nagoya City West Medical Center), Tohru Takahashi (Tenshi Hospital), Hirotsugu Kojima (Daido Hospital), Kazuki Tanimoto (Fukuoka Red Cross Hospital), Katsumichi Fujimaki (Fujisawa City Hospital), Yasushi Terasaki (Toyama City Hospital), Hirokazu Okumura (Toyama Prefectural Central Hospital), Tsuyoshi Nakamaki (Showa University School of Medicine), Norisato Hashimoto (Tokai University Hachioji Hospital), Masahide Yamazaki (Keiju Medical Center), Masayuki Ohnishi (Niigata Minami Hospital), Akio Saitoh (Fujioka General Hospital), Tomoyuki Imamura (Oita Memorial Hospital), Hiroto Kaneko (Aiseikai Yamashina Hospital), Masahiro Fujiwara (Kashiwazaki General Hospital and Medical Center), Naoki Harada (Chihaya Hospital), Masato Shikami (Daiyukai General Hospital), Takahiro Karasuno (Rinku General Medical Center), Nobuhisa Hirase (Nakatsu Municipal Hospital), Masanobu Nakata (Seirei Hamamatsu General Hospital), Yoshihito Iwahara (National Hospital Organization Kochi National Hospital), Tatsuyuki Hayashi (Tokyo Metropolitan Police Hospital), Sachiya Takemura (Yokohama Ekisaikai Hospital), Masaru Shibano (Sakai City Medical Center), Naoki Takezako (National Hospital Organization Disaster Medical Center). This work was supported by the grant (Takeda Research Support) from Takeda Pharmaceutical Company (to M.S.). |
